Yohei Takumi
Overview
Explore the profile of Yohei Takumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Miyawaki M, Ogawa K, Kamada K, Karashima T, Abe M, Takumi Y, et al.
J Cardiothorac Surg
. 2023 Jan;
18(1):26.
PMID: 36647124
Background: Dog bites associated with the head and neck area in children are a common problem. Most of the lacerations are found in the upper lip and the nose region,...
12.
Takumi Y, Arai S, Suzuki C, Fukuda K, Nishiyama A, Takeuchi S, et al.
Cancer Med
. 2022 Nov;
12(5):5809-5820.
PMID: 36416133
Background: Entrectinib is an effective drug for treating solid tumors with NTRK gene rearrangement and non-small cell lung cancer (NSCLC) with ROS1 gene rearrangement. However, its efficacy is limited by...
13.
Suzuki C, Nishiyama A, Arai S, Tange S, Tajima A, Tanimoto A, et al.
Cancer Sci
. 2022 Apr;
113(7):2323-2335.
PMID: 35363931
Tropomyosin receptor kinase (TRK) inhibitors have demonstrated histology-agnostic efficacy in patients with neurotrophic receptor tyrosine kinase (NTRK) gene fusion. Although responses to TRK inhibitors can be dramatic and durable, duration...
14.
Okamoto T, Miyawaki M, Toyokawa G, Karashima T, Abe M, Takumi Y, et al.
Interact Cardiovasc Thorac Surg
. 2021 Sep;
34(2):219-226.
PMID: 34561707
Objectives: The ground-glass component of part-solid tumour (PST) was eliminated as a clinical T (cT) descriptor in the eighth edition of the tumour, node and metastasis (TNM) staging system. We...
15.
Sakaguchi H, Tanimoto A, Sato S, Yanagimura N, Suzuki C, Takumi Y, et al.
Intern Med
. 2021 Jun;
61(1):75-79.
PMID: 34176837
Primary malignant melanoma (MM) of the mediastinum is rare, and there is a lack of consensus regarding the preferred treatment because non-cutaneous MM demonstrates an inferior response to systemic therapy....
16.
Sato S, Tanimoto A, Yanagimura N, Suzuki C, Takumi Y, Nishiyama A, et al.
Int J Clin Oncol
. 2021 Mar;
26(6):1009-1014.
PMID: 33646436
Background: Potential disparities between cancer patients with and without disabilities remained to be validate in Japan. Methods: We surveyed retrospective data on hospital cancer registration as well as information on...
17.
Noda D, Abe M, Takumi Y, Anami K, Miyawaki M, Takeuchi H, et al.
Surg Case Rep
. 2021 Jan;
7(1):28.
PMID: 33471222
Background: Surgery is an effective treatment for desmoid fibromatosis, but it may be difficult, depending on the location or local spread of the tumor, and the decision to perform surgery...
18.
Abe M, Osoegawa A, Miyawaki M, Noda D, Karashima T, Takumi Y, et al.
Gen Thorac Cardiovasc Surg
. 2019 Nov;
68(11):1344-1349.
PMID: 31749068
Ciliated muconodular papillary tumor (CMPT) of the lung is characterized as a peripheral low-grade malignant tumor with ciliated columnar cells and goblet cells with basaloid cell proliferation. Herein, we report...
19.
Abe M, Osoegawa A, Karashima T, Takumi Y, Kobayashi R, Hashimoto T, et al.
Int Cancer Conf J
. 2019 Jun;
8(2):81-85.
PMID: 31149553
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors remains the main hurdle in treating EGFR-mutated lung cancer. Besides, when leptomeningeal carcinomatosis occurs during treatment, it often leads to...
20.
Takeuchi H, Abe M, Takumi Y, Hashimoto T, Miyawaki M, Okamoto T, et al.
Sci Rep
. 2019 Mar;
9(1):3033.
PMID: 30816333
Red cell distribution width (RDW) to platelet ratio (RPR) is a prognosticator in acute pancreatitis and myocardial infarction; however, the prognostic values of RDW and RPR in breast cancer have...